-
On October 10, 2025, President Donald Trump announced a deal with AstraZeneca to lower drug prices for Medicaid patients by matching the lowest prices in developed countries. The agreement includes AstraZeneca's commitment to invest $50 billion in U.S. manufacturing by 2030 and participation in the upcoming TrumpRx website, which will sell discounted drugs directly to consumers starting in early 2026.
-
Former President Clinton highlighted the rise in political violence and misinformation, emphasizing the importance of global health initiatives like HIV prevention programs. He also discussed recent debates over vaccine policies and experimental autism treatments, framing these issues within broader concerns about misinformation and government response. Today’s date: Thu, 25 Sep 2025 02:45:02 +0100.
-
A rare arrest warrant has been issued for a California doctor for violating Louisiana's abortion ban by providing pills via telehealth. This highlights ongoing legal battles over prescribing abortion medication across state lines following the overturn of Roe v. Wade. The case involves multiple states and legal strategies to restrict access.
-
The FDA approved a low-cost generic form of mifepristone, a drug used for early pregnancy termination, despite ongoing safety reviews and political criticism. The decision has sparked debate over drug safety, regulatory processes, and abortion access, with opponents calling the move reckless and proponents emphasizing safety data.